|  Research Summary  |  Publications  |

Research Summary

Ongoing Clinical Trials

1. 2007 Rheos - Prospective, randomized, multi-center pivotal trial evaluating the efficacy of the Rheos Baroreceptor System in controlling hypertension refractory to best medical therapy. (Role: PI)

2. 2008 Proteon - Phase 1-2, multi-center, dose-escalation study of a single dose of PRT-201 administered immediately after arteriovenous fistula creation in patients with chronic kidney disease (Pending.  Role: PI.)

3. Co-Investigator in 10 active divisional and inter-disciplinary clinical trials.

4. Data Safety Monitoring Board, iCast Trial: 2007 Multicenter, prospective evaluation of efficacy of covered self-expanding Atrium iCast stent for iliac artery occlusive disease. (Regulatory Involvement)

Completed Clinical Trials

5. 2007 DuraSeal - Prospective, randomized trial comparing DuraSeal topical sealant to thrombin-soaked gelfoam for operative hemostasis with PTFE graft anastomoses. (Role: PI)

Back to the top

Publications

To access Dr. Matthew Menard's publications, please click here.

Back to the top

Matthew Menard
MD

Clinical Profile & Contact Information

Research Interests

Rheos Baroreceptor System
Treatment After Arteriovenous Fistula Creation
Atrium iCast Stent Use for Iliac Artery Occlusive Disease